EN
HI
Summary
As of 30 Aug, 2026, Syncom Formulations (India) stock price is ₹19.46. During the trading session, the stock has moved between an intraday low of ₹17.26 and an intraday high of ₹20.38. Over the last 52 weeks, Syncom Formulations (India) has traded between ₹10.21 and ₹20.38.
The stock has recorded a trading volume of 5,71,35,698 shares, with a market capitalization of ₹940000000. Its Average Traded Price (ATP) is ₹19.40, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 149 @ ₹19.46.
Syncom Formulations (India) has an upper circuit limit of ₹23.35 and a lower circuit limit of ₹15.57. The total value traded stands at ₹110.84 CR, and the delivery percentage for the day is 31.34%.
The stock is currently traded with a market lot size of 1. Syncom Formulations (India) also offers a dividend yield of 0%.
Syncom Formulations (India) share price chart
Syncom Formulations (India) Share Key Metrics
Volume
5.71 CR
Market Cap
1829.24 CR
LTQ@LTP
149@19.46
ATP
19.4
Var Margin
21.62 %
Circuit Range
15.57-23.35
Delivery %
31.34 %
Value
110.84 CR
ASM/GSM
No
Market Lot
1
Syncom Formulations (India) Fundamentals
P/E Ratio
21.39
P/B Ratio
4.16
Div. Yield
0
Sector P/E
69.42
Sector P/B
3.5
Sec. Div. Yield
0.51
Syncom Formulations (India) Resistance and Support
Pivot 17.6
Resistance
First Resistance
18.07
Second Resistance
18.81
Third Resistance
19.28
Support
First Support
16.86
Second Support
16.39
Third Support
15.65
Syncom Formulations (India) Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 28 2026 | 17.67 | 19.46 | 12.23% | 20.38 | 17.26 |
| Thu Aug 27 2026 | 17.14 | 17.34 | 1.82% | 18.34 | 17.12 |
| Wed Aug 26 2026 | 17.68 | 17.03 | -2.96% | 17.73 | 16.86 |
Syncom Formulations (India) Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-05-22 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-05-19 | Audited Results |
| 2025-02-10 | Quarterly Results & Others |
| 2024-11-11 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
Syncom Formulations (India) News
Syncom Formulations India Ltd-$ - 524470 - Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015('Listing Regulations'): Press Release
Syncom Formulations announced Q1 FY27 financial results. Net profit increased 58% YoY to Rs.24.85 crore and revenue grew 7% to Rs.125.53 crore, reflecting strong performance. The board also recommended a final dividend of Rs.0.10 per equity share for FY26.
Aug 13 2026 17:52:07
Syncom Formulations India Ltd-$ - 524470 - Announcement under Regulation 30 (LODR)-Change in Management
Syncom Formulations announced the appointment of Shri Rahul Vijay Bankda as the new Managing Director, effective August 12, 2026. This appointment is in the best interest of the organization and is subject to approval from shareholders at the ensuing Annual General Meeting.
Aug 11 2026 19:18:04
Read More
Syncom Formulations (India) Management
| Name | Position |
|---|---|
| Vaishali Agrawal | Company Secretary & Compliance Officer |
| Vijay Shankarlal Bankda | Managing Director |
Syncom Formulations (India) Similar Stocks
Shukra Pharmaceuticals Ltd.
44.28
0.06 (0.14%)
Krsnaa Diagnostics Ltd.
564.05
6.35 (1.14%)
NGL Fine-Chem Ltd.
2813.40
-87.70 (3.02%)
Suraksha Diagnostic Ltd.
340.20
4.80 (1.43%)
Shalby Ltd.
154.65
0.32 (0.21%)
Amrutanjan Health Care Ltd.
514.25
-2.80 (0.54%)
Jagsonpal Pharmaceuticals Ltd.
239.06
2.07 (0.87%)
Fermenta Biotech Ltd.
509.90
23.65 (4.86%)
KMC Speciality Hospitals (India) Ltd.
138.05
-0.13 (0.09%)
Syncom Formulations (India) FAQs
The Buying Price of Syncom Formulations (India) share is 19.46 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Syncom Formulations (India) stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Syncom Formulations (India), choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Syncom Formulations (India) shares is 21.39. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Syncom Formulations (India) shares is 4.16. Useful to assess the stock's value relative to its book value.
To assess Syncom Formulations (India)’s valuation compare Sector P/E, P/B which are 69.42 & 3.5 with sector averages, along with growth rates and financial metrics.
The Market Cap of Syncom Formulations (India) is 1829.24 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Syncom Formulations (India) share price is 20.38 & 10.21. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Syncom Formulations (India) belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
